MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,327,000 | +87.2% | 34,670 | +129.4% | 0.00% | +100.0% |
| Q1 2022 | $1,243,000 | -63.9% | 15,115 | -35.5% | 0.00% | -50.0% |
| Q4 2021 | $3,442,000 | -40.0% | 23,427 | -27.7% | 0.00% | -50.0% |
| Q3 2021 | $5,735,000 | +50.0% | 32,421 | +36.9% | 0.00% | +33.3% |
| Q2 2021 | $3,824,000 | -5.1% | 23,674 | +0.6% | 0.00% | -25.0% |
| Q1 2021 | $4,031,000 | -27.3% | 23,531 | -6.8% | 0.00% | -20.0% |
| Q4 2020 | $5,544,000 | +48.8% | 25,244 | +12.5% | 0.01% | +25.0% |
| Q3 2020 | $3,725,000 | +46.3% | 22,430 | +0.6% | 0.00% | +33.3% |
| Q2 2020 | $2,547,000 | +218.8% | 22,307 | +114.8% | 0.00% | +200.0% |
| Q1 2020 | $799,000 | -81.6% | 10,386 | -69.2% | 0.00% | -75.0% |
| Q4 2019 | $4,343,000 | +523.1% | 33,707 | +285.6% | 0.00% | +300.0% |
| Q3 2019 | $697,000 | -21.9% | 8,741 | +0.9% | 0.00% | 0.0% |
| Q2 2019 | $892,000 | -65.6% | 8,663 | -75.5% | 0.00% | -66.7% |
| Q1 2019 | $2,592,000 | – | 35,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |